| Literature DB >> 34067722 |
Zainab Akhter1, Nicola Heslehurst1, Dries Ceulemans2, Judith Rankin1, Roger Ackroyd3, Roland Devlieger2.
Abstract
Bariatric surgery prior to pregnancy is a significant risk factor for small for gestational age (SGA) babies. This case-control study investigated differences between mothers delivering an SGA baby following bariatric surgery, compared to those delivering an appropriate for gestational age (AGA) baby. Out of 129 babies born to mothers in the AURORA cohort study, 25 were SGA (<10th percentile) and 97 were AGA (10th-90th percentile). Higher gestational weight gain (GWG) was significantly associated with decreased odds of SGA (aOR per kg 0.92, 95% CI 0.85-0.99). According to the Institute of Medicine GWG guidelines, 44% of SGA mothers had 'inadequate' GWG compared to 17% of AGA mothers. Nearly half of the mothers had 'excessive' GWG yet still gave birth to an SGA or AGA baby. Mothers of SGA babies lost more weight following bariatric surgery (45.6 ± 14.4 kg vs. 39.0 ± 17.9 kg). Women who reported receiving nutritional advice following bariatric surgery were significantly less likely to have an SGA baby (aOR 0.15, 95% CI 0.0.4-0.55). Women with a history of bariatric surgery should be provided with specialized support before and during pregnancy to encourage adequate nutritional intake and weight gain to support healthy fetal growth.Entities:
Keywords: bariatric surgery; fetal growth; gestational weight gain; nutrition; obesity; pregnancy
Mesh:
Year: 2021 PMID: 34067722 PMCID: PMC8156275 DOI: 10.3390/nu13051699
Source DB: PubMed Journal: Nutrients ISSN: 2072-6643 Impact factor: 5.717
Institute of Medicine 2009 guidance for GWG in pregnancy [18].
| Pre-Pregnancy BMI | Total Weight Gain Range (kg) |
|---|---|
| Underweight (<18.5 kg/m2) | 12.5–18 |
| Recommended (18.5–25 kg/m2) | 11.5–16 |
| Overweight (25–30 kg/m2) | 7–11.5 |
| Obesity (>30 kg/m2) | 5–9 |
Figure 1Inclusion of case and control babies in the AURORA dataset.
Figure 2AURORA cohort babies plotted against 10th and 90th size for gestational age percentiles for birth weight, gestational age, infant sex, and parity in Flanders, Belgium using SPE data: (a) primiparous boys; (b) multiparous boys; (c) primiparous girls; (d) multiparous boys.
Characteristics of babies born to mothers in AURORA.
| Infant | Total | SGA | AGA | |
|---|---|---|---|---|
|
| ||||
| Boys | 69 (56.6%) | 15 (60.0%) | 54 (55.7%) | 0.697 |
| Girls | 53 (43.4%) | 10 (40.0%) | 43 (44.3%) | |
|
| ||||
| Mean ± SD | 3064.1 ± 535.5 | 2594.4 ± 328.0 | 3185.2 ± 512.1 | 0.000 |
| <2500 g | 16 (13.0%) | 9 (36.0%) | 7 (7.2%) | 0.002 |
| 2500–4000 g | 103 (84.4%) | 16 (64%) | 87 (89.7%) | |
| ≥4000 g | 3 (2.5%) | 0 | 3 (3.1%) | |
|
| ||||
| Mean ± SD | 38.4 ± 1.9 | 38.6 ± 1.6 | 38.3 ± 2.0 | 0.696 |
| <37 weeks | 19 (15.6%) | 4 (16.0%) | 15 (15.5%) | 1.000 |
| 37–42 weeks | 103 (84.4%) | 21 (84.0%) | 82 (84.5%) | |
| ≥42 weeks | 0 | 0 | 0 |
Sociodemographic characteristics and clinical factors of mothers in AURORA.
| Maternal | Total | SGA | AGA | |
|---|---|---|---|---|
| 30.1 ± 4.6 | 30.4 ± 4.7 | 30 ± 4.5 | 0.727 | |
| 165.5 ± 6.9 | 164.1 ± 5.7 | 165.8 ± 7.2 | 0.267 | |
|
| ||||
| Nulliparous | 38 (31.2%) | 8 (32%) | 30 (30.9%) | 0.586 |
| Multiparous | 77 (63.1%) | 13 (52%) | 64 (66%) | |
|
| ||||
| Underweight <18.5 | 2 (1.6%) | 2 (8%) | 0 | 0.193 |
| Recommended 18.5–24.9 | 34 (27.9%) | 7 (28%) | 27 (27.8%) | |
| Overweight 25.0–29.9 | 46 (37.7%) | 9 (36%) | 37 (38.1%) | |
| Obesity class I 30–34.9 | 24 (19.7%) | 6 (24%) | 18 (18.6%) | |
| Obesity class II 35–39.9 | 14 (11.5%) | 1 (0.4%) | 13 (13.4%) | |
| Obesity class III ≥ 40 | 1 (0.8%) | 0 | 1 (1%) | |
|
| ||||
| Overweight 25.0–29.9 | 1 (0.9%) | 0 | 1 (1%) | 0.477 |
| Obesity class I 30–434.9 | 7 (5.7%) | 0 | 7 (7.1%) | |
| Obesity class II 35–39.9 | 29 (23.8%) | 8 (32%) | 21 (21.6%) | |
| Obesity class III ≥ 40 | 77 (63.1%) | 16 (64%) | 61 (62.9%) | |
|
| ||||
| White European | 63 (51.6%) | 13 (52%) | 50 (51.5%) | 1.000 |
| Other | 8 (6.6%) | 1 (4%) | 7 (7.2%) | |
|
| ||||
| Married | 38 (31.2%) | 3 (12%) | 35 (36.1%) | 0.046 |
| Single | 29 (23.8%) | 8 (32%) | 21 (21.6%) | |
|
| ||||
| Higher education | 20 (16.4%) | 1 (4%) | 19 (19.6%) | 0.153 |
| Secondary or below | 47 (38.5%) | 10 (40%) | 37 (38.1%) | |
|
| ||||
| Full or part-time work | 38 (31.2%) | 3 (12%) | 35 (36.1%) | 0.046 |
| Unemployed | 29 (23.8%) | 8 (32%) | 21 (21.6%) | |
|
| ||||
| Spontaneous | 105 (86.1%) | 25 (100%) | 80 (82.5%) | 0.039 |
| Fertility treatment | 14 (11.5%) | 0 | 14 (14.4%) | |
|
| ||||
| RYGB | 89 (73.0%) | 20 (80%) | 69 (71.1%) | 0.962 |
| LAGB | 19 (15.6%) | 3 (12%) | 16 (16.5%) | |
| SG | 9 (7.4%) | 2 (8%) | 7 (7.2%) | |
| BPD | 3 (2.5%) | 0 | 3 (3.1%) |
Percentages do not add up to 100 in the case of missing data (Table S1).
Analysis of maternal modifiable factors’ association with SGA.
| Modifiable Factors | Total | SGA | AGA | Sig. Test | OR (95% CI) | |
|---|---|---|---|---|---|---|
| 12.3 ± 6.5 | 9.8 ± 7.1 | 13.0 ± 6.2 | 0.023 | 0.92 (0.85–0.99) | 0.029 | |
|
| ||||||
| Inadequate | 27 (22.1%) | 11 (44.0%) | 16 (16.5%) | 0.012 | 2.55 (0.82–7.93) | 0.105 |
| Recommended | 33 (27.0%) | 7 (28.0%) | 26 (26.8%) | Reference group | - | |
| Excessive | 57 (46.7%) | 7 (28.0%) | 50 (51.5%) | 0.52 (0.16–1.64) | 0.265 | |
|
| ||||||
| Yes | 58 (47.5%) | 8 (32.0%) | 50 (51.5%) | 0.004 | 0.14 (0.04–0.51) | 0.003 |
| No | 13 (10.7%) | 7 (28.0%) | 6 (6.2%) | Reference group | - | |
|
| ||||||
| Yes | 10 (8.2%) | 4 (16.0%) | 6 (6.2%) | 0.082 | 3.83 (0.88–16.69) | 0.073 |
| No | 54 (44.3%) | 8 (32.0%) | 46 (47%) | Reference group | - | |
|
| ||||||
| More than once a month | 24 (19.7%) | 2 (8.0%) | 22 (22.7%) | 0.123 | 0.29 (0.06–1.49) | 0.14 |
| Once a month or less | 38 (31.1%) | 9 (26.0%) | 29 (30.0%) | Reference group | - |
Percentages do not add up to 100 in the case of missing data (Table S1). Significance test p values were calculated using t test, Mann-Whitney U test, Pearson’s χ2 test, or Fisher’s exact test. OR (95% CI) and subsequent p values are calculated from univariate logistic regression.
Figure 3Age-adjusted analysis of maternal factors and their association with SGA. Modifiable factors are highlighted in pink, and clinical indicators are highlighted in blue. * The result for hypertension is a crude odds ratio (95% CI) due to zero cases in the SGA group.
Analysis of maternal nutritional biomarkers’ association with SGA.
| Serum Levels | Reference Range * | AURORA | SGA | AGA | |
|---|---|---|---|---|---|
| 9.7–14.7 | 8.7–13.9 (110) | 11.3 ± 1.3 | 11.4 ± 1.1 | 0.851 | |
| 2.81–4.49 | 3.12–4.94 (100) | 3.87 ± 0.35 | 3.90 ± 0.34 | 0.777 | |
| 44–178 | 24–169 (49) | 81.1 ± 41.0 | 90.1 ± 38.4 | 0.517 | |
| 0.8–24 | 4.4–19.7 (77) | 15.9 ± 5.0 | 14.3 ± 5.1 | 0.245 | |
| 130–656 | 77–760 (103) | 207.8 ± 95.2 | 236.9 ± 110.6 | 0.232 | |
| 2.05–2.25 | 2.08–2.39 (34) | 2.22 ± 0.08 | 2.26 ± 0.08 | 0.276 | |
| 10–22 | 4.5–68 (87) | 33.2 ± 15.3 | 29.1 ± 13.3 | 0.373 | |
| 25–45 | 29.8–41.4 (76) | 36.8 ± 2.6 | 37.1 ± 2.3 | 0.951 |
* Reference ranges for serum levels specific to the second trimester of pregnancy [23]. RBC: red blood cell, 25-OH: 25-hydroxy. p values were calculated using t test or Mann-Whitney U test.
Analysis of maternal clinical indicators’ association with SGA.
| Clinical Indicators | Total | SGA | AGA | Sig. Test | OR (95% CI) | |
|---|---|---|---|---|---|---|
|
| ||||||
| Mean ± SD | 28.3 ± 5.1 | 26.4 ± 5.0 | 28.8 ± 5.1 | 0.066 | ||
| per 1 kg/m2 increase | 0.90 (0.81–0.99) | 0.038 | ||||
| per 5 kg/m2 increase | 0.58 (0.35–0.97) | 0.038 | ||||
|
| ||||||
| Yes | 28 (23%) | 4 (16%) | 24 (24.7%) | 0.541 | 0.69 (0.21–2.29) | 0.543 |
| No | 77 (63.1%) | 15 (60%) | 62 (63.9%) | Reference group | - | |
|
| ||||||
| Yes | 7 (5.7%) | 0 | 7 (7.2%) | 0.342 | * 0.24 (0.01–4.37) | 0.336 |
| No | 112 (91.8%) | 24 (96%) | 88 (90.7%) | Reference group | - | |
|
| ||||||
| RYGB/BPD | 92 (76.7%) | 20 (80%) | 72 (74.2%) | 0.658 | 1.28 (0.43–3.79) | 0.658 |
| LAGB/SG | 28 (23.3%) | 5 (20%) | 23 (23.7%) | Reference group | - | |
| 49.8 ± 37.5 | 48.9 ± 34.0 | 50.0 ± 38.5 | 0.856 | 1.00 (0.99–1.01) | 0.890 | |
| 40.4 ± 17.4 | 45.6 ± 14.4 | 39.0 ± 17.9 | 0.057 | 1.02 (1.00–1.05) | 0.100 |
Percentages do not add up to 100 in the case of missing data (Table S1). Significance test p values were calculated using t test, Mann-Whitney U test, Pearson’s χ2 test, or Fisher’s exact test. OR (95% CI) and subsequent p values are calculated from univariate logistic regression. * Hypertension OR (95% CI) was calculated by substituting zero cases to 0.5.